234 related articles for article (PubMed ID: 9197477)
1. Potential biomarkers in predicting progression of epithelial hyperplastic lesions of the larynx.
Gallo O; Franchi A; Chiarelli I; Porfirio B; Grande A; Simonetti L; Bocciolini C; Fini-Storchi O
Acta Otolaryngol Suppl; 1997; 527():30-8. PubMed ID: 9197477
[TBL] [Abstract][Full Text] [Related]
2. Increased mutagen-induced chromosome damage in patients with transformed laryngeal pre-cancerosis.
Gallo O; Santoro R; Lenzi S; Boddi V; Giovannucci-Uzielli ML
Int J Cancer; 1996 Dec; 68(6):700-3. PubMed ID: 8980169
[TBL] [Abstract][Full Text] [Related]
3. Hyperplastic lesions of the larynx. Experience of the Barcelona group.
Cardesa A; Nadal A; Jares P; Mallofré C; Fernández PL; Campo E; Traserra J
Acta Otolaryngol Suppl; 1997; 527():43-6. PubMed ID: 9197479
[TBL] [Abstract][Full Text] [Related]
4. Morphological assessment of malignant potential of epithelial hyperplastic lesions.
Burkhardt A
Acta Otolaryngol Suppl; 1997; 527():12-6. PubMed ID: 9197473
[TBL] [Abstract][Full Text] [Related]
5. Value of exfoliative cytology in differential diagnosis of epithelial hyperplastic lesions of the larynx.
Beham A; Regauer S; Friedrich G; Beham-Schmid C
Acta Otolaryngol Suppl; 1997; 527():92-4. PubMed ID: 9197491
[TBL] [Abstract][Full Text] [Related]
6. Quantitative pathology of laryngeal epithelial hyperplastic lesions.
Cör A; Gale N; Kambic V
Acta Otolaryngol Suppl; 1997; 527():57-61. PubMed ID: 9197483
[TBL] [Abstract][Full Text] [Related]
7. Morphometric analysis of Ki-67 and p16 expression in laryngeal precursor lesions.
Pavlovic B; Djukic V; Milovanovic J; Tomanovic N; Milovanovic A; Trivic A
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1405-10. PubMed ID: 23408022
[TBL] [Abstract][Full Text] [Related]
8. Induction of the CBP transcriptional co-activator early during laryngeal carcinogenesis.
Karamouzis MV; Papadas T; Varakis I; Sotiropoulou-Bonikou G; Papavassiliou AG
J Cancer Res Clin Oncol; 2002 Mar; 128(3):135-40. PubMed ID: 11935299
[TBL] [Abstract][Full Text] [Related]
9. p53 immunostaining and image cytometry DNA analysis in precancerous and cancerous squamous epithelial lesions of the larynx.
Munck-Wikland E; Kuylenstierna R; Lindholm J; Auer G
Head Neck; 1997 Mar; 19(2):107-15. PubMed ID: 9059867
[TBL] [Abstract][Full Text] [Related]
10. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx.
Zidar N; Gale N; Cör A; Kambic V
J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
Gale N; Zidar N; Kambic V; Poljak M; Cör A
Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
[TBL] [Abstract][Full Text] [Related]
12. Lack of detection of human papillomavirus (HPV) in transformed laryngeal keratoses by in situ hybridization (ISH) technique.
Gallo O; Bianchi S; Giannini A; Boccuzzi S; Calzolari A; Fini-Storchi O
Acta Otolaryngol; 1994 Mar; 114(2):213-7. PubMed ID: 8203204
[TBL] [Abstract][Full Text] [Related]
13. Molecular biopathology of metaplastic, dysplastic, and neoplastic laryngeal epithelium.
Resta L; Marsigliante S; Leo G; Fiorella R; Di Nicola V; Maiorano E
Acta Otolaryngol Suppl; 1997; 527():39-42. PubMed ID: 9197478
[TBL] [Abstract][Full Text] [Related]
14. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
15. Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal lesions.
Gale N; Kambic V; Poljak M; Cör A; Velkavrh D; Mlacak B
Oncology; 2000 Feb; 58(2):117-25. PubMed ID: 10705238
[TBL] [Abstract][Full Text] [Related]
16. Chromosome instability as an indicator of malignant progression in laryngeal mucosa.
Veltman JA; Bot FJ; Huynen FC; Ramaekers FC; Manni JJ; Hopman AH
J Clin Oncol; 2000 Apr; 18(8):1644-51. PubMed ID: 10764424
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of p27 is correlated with progression in precancerous lesions of the larynx.
Hirai T; Hayashi K; Takumida M; Ueda T; Hirakawa K; Yajin K
Auris Nasus Larynx; 2003 May; 30(2):163-8. PubMed ID: 12753988
[TBL] [Abstract][Full Text] [Related]
19. Epithelial hyperplastic lesions--a challenging topic in laryngology.
Kambic V
Acta Otolaryngol Suppl; 1997; 527():7-11. PubMed ID: 9197472
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
